Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AYO TRIAL
PACTR201906662822573Completed
- Sponsor
- AYO OKWUOSA
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of nifedipine and hydralazine in maternal hypertension (HDP) (2 arms), sponsored by AYO OKWUOSA. Primary endpoint: Time to achieve target blood pressure. Started Jun 2019; status: completed.
02
Drugs
nifedipinehydralazine
03
Conditions
maternal hypertension (HDP)
Beyond the preview
Go deeper on PACTR201906662822573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201906662822573.